Copyright © 2013 Chellakkan Selvanesan Benson et al. This is an open access article distributed under the Creative Commons At-tribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is prop-erly cited. Growth factor signaling plays a key role in the growth and development of breast. Aberrant expression and activation of growth factors like insulin like growth factor-I (IGF-I) and epidermal growth factor (EGF) and their downstream sig-naling has been implicated in breast cancer. The deregulation of growth factor signaling is associated with increased proliferation and cell survival, decreased apoptosis, invasion, angiogenesis and metastasis. The aim of the present study is t...
Activation of the insulin-like growth factor-1 receptor (IGF-11R) by IGF-1 is associated with the ri...
The insulin-like growth factor (IGF) family of ligands, binding proteins and receptors is an importa...
Triple-negative breast cancers have a poor prognosis and are not amenable to endocrine- or HER2-targ...
Despite extensive research, the pathways of breast cancer development remains largely unknown. Ident...
In this review, we provide an overview of the role of the insulin-like growth factor (IGF) signaling...
Cross-talk between insulin-like growth factor (IGF)- and estrogen receptor (ER)-signaling pathways r...
Fibroblast growth factors (FGFs), master regulators of cell functions, activate intracellular signal...
Introduction: Triple-negative breast cancer (TNBC) is characterised by the absence of oestrogen rece...
Introduction: Triple-negative breast cancer (TNBC) is characterised by the absence of oestrogen rece...
This review aims to summarize experimental evidence supporting the role of the insulin-like growth f...
textabstractEpidermal growth factor (EGF) is a 53-aminoacid polypeptide (mol wt 6.045 K) that can in...
AbstractActivation of the insulin-like growth factor-1 receptor (IGF-11R) by IGF-1 is associated wit...
The insulin-like growth factor (IGF) pathway consists of two ligands (IGF-I and IGF-II), two recepto...
Introduction/Objective. Activation of insulin-like growth factor receptor (IGF-1R) results in cell t...
AbstractWe examined transforming growth factor (TGF) α, epidermal growth factor (EGF) and EGF recept...
Activation of the insulin-like growth factor-1 receptor (IGF-11R) by IGF-1 is associated with the ri...
The insulin-like growth factor (IGF) family of ligands, binding proteins and receptors is an importa...
Triple-negative breast cancers have a poor prognosis and are not amenable to endocrine- or HER2-targ...
Despite extensive research, the pathways of breast cancer development remains largely unknown. Ident...
In this review, we provide an overview of the role of the insulin-like growth factor (IGF) signaling...
Cross-talk between insulin-like growth factor (IGF)- and estrogen receptor (ER)-signaling pathways r...
Fibroblast growth factors (FGFs), master regulators of cell functions, activate intracellular signal...
Introduction: Triple-negative breast cancer (TNBC) is characterised by the absence of oestrogen rece...
Introduction: Triple-negative breast cancer (TNBC) is characterised by the absence of oestrogen rece...
This review aims to summarize experimental evidence supporting the role of the insulin-like growth f...
textabstractEpidermal growth factor (EGF) is a 53-aminoacid polypeptide (mol wt 6.045 K) that can in...
AbstractActivation of the insulin-like growth factor-1 receptor (IGF-11R) by IGF-1 is associated wit...
The insulin-like growth factor (IGF) pathway consists of two ligands (IGF-I and IGF-II), two recepto...
Introduction/Objective. Activation of insulin-like growth factor receptor (IGF-1R) results in cell t...
AbstractWe examined transforming growth factor (TGF) α, epidermal growth factor (EGF) and EGF recept...
Activation of the insulin-like growth factor-1 receptor (IGF-11R) by IGF-1 is associated with the ri...
The insulin-like growth factor (IGF) family of ligands, binding proteins and receptors is an importa...
Triple-negative breast cancers have a poor prognosis and are not amenable to endocrine- or HER2-targ...